Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
21NT
HER2amp
-
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14610.189
uM
0.28136
0.47547
-0.9402 -0.9548 2.0356 0.7876
0.9958
1.0787
21PT
HER2amp
-
Bortezomib
Proteasome
Proteasome
14715.203
uM
0.01691
0.02685
-0.7771 -0.7768 2.0279 1.0962
0.9968
2.0168
21PT
HER2amp
-
Bortezomib
Proteasome
Proteasome
14715.203
uM
0.01691
0.02685
-0.7771 -0.7768 2.0279 1.0962
0.9968
2.0168
CAL-148
TNBC
-
Bortezomib
Proteasome
Proteasome
15276.203
uM
0.04767
0.09858
-0.8960 -0.9196 1.4362 1.0010
0.9955
1.6831
MCF 10F
NM
-
Bortezomib
Proteasome
Proteasome
7487.074
uM
0.14698
0.69853
-0.9095 -0.9810 0.6967 0.8500
0.9984
1.4197
MCF 10F
NM
-
Carboplatin
DNA cross-linker
DNA cross-linker
9566.011
uM
50.05840
101.28940
-0.7823 -0.8360 1.3945 0.3717
0.9990
2.3358
MCF 10F
NM
-
Cetuximab
EGFR
ErbB
7871.018
uM
inf
inf
0.9011 0.9011 0.0000 -0.0407
-0.0154
1.1973
CAL-148
TNBC
-
Bortezomib
Proteasome
Proteasome
15276.203
uM
0.04767
0.09858
-0.8960 -0.9196 1.4362 1.0010
0.9955
1.6831
MCF 10F
NM
-
Cetuximab
EGFR
ErbB
7487.102
uM
1.06250
14.53060
0.5584 -1.0000 0.4200 0.0918
0.9670
1.5273
MCF 10F
NM
-
CGC-11047
Polyamine analogue
9566.026
uM
528.70890
925.43090
-0.8038 -0.8874 1.8230 0.3767
0.9064
2.1367
MCF 10F
NM
-
Cisplatin
DNA cross-linker
DNA cross-linker
7872.017
uM
inf
inf
1.0147 1.0147 0.0000 0.0576
0.1865
1.5155
CAL-85-1
TNBC
-
Bortezomib
Proteasome
Proteasome
15280.203
uM
0.00265
0.00507
-0.9828 -0.9851 1.6797 1.4734
0.9952
0.7211
MCF 10F
NM
-
(Z)-4-Hydroxytamoxifen
ESR1
7872.016
uM
7.35710
5.64830
0.1459 0.2589 2.7594 0.2512
0.8956
1.4834
MCF 10F
NM
-
Dichloroacetate
PDK
PDK
13750.176
uM
inf
inf
0.8474 0.8474 0.0000 0.0585
0.2166
1.5387
MCF 10F
NM
-
Disulfiram
Proteasome
Proteasome
13750.174
uM
inf
inf
0.7281 0.7281 0.0000 0.1301
0.5378
1.4282
CAL-85-1
TNBC
-
Bortezomib
Proteasome
Proteasome
15280.203
uM
0.00265
0.00507
-0.9828 -0.9851 1.6797 1.4734
0.9952
0.7211
CAL-85-1
TNBC
-
Torkinib
15280.211
uM
0.00057
0.00844
-0.8064 -0.8633 0.3733 1.1993
0.9944
0.8608
CAL-85-1
TNBC
-
Ribavirin
15280.211
uM
104.41110
45.7480
0.6941 0.4856 4.2943 -0.0088
0.8805
0.8608
MCF 10F
NM
-
Doxorubicin
TOP2
TOP
9566.121
uM
0.64040
1.03820
-0.7383 -0.7411 1.8818 0.6289
0.9914
2.3089
MCF 10F
NM
-
(Z)-4-Hydroxytamoxifen
ESR1
7871.016
uM
inf
34.66260
0.8429 0.8429 4.9988 -0.0104
0.6376
1.0272
MCF 10F
NM
-
Erlotinib
EGFR
ErbB
7487.09
uM
0.20420
0.24610
-0.2461 -0.1722 1.5855 0.4893
0.9936
1.5226
MCF 10F
NM
-
Everolimus
MTOR
MTOR
12254.164
uM
1.64590
87.8530
-0.0725 -1.0000 0.2762 0.3434
0.8749
1.4589
MCF 10F
NM
-
Fascaplysin
CDK4
CDK
7487.084
uM
0.27808
0.47257
-0.9814 -0.9785 2.0446 0.6770
0.9945
1.3396
SUM229PE
TNBC
-
Ribavirin
15359.211
uM
inf
inf
0.9761 0.9761 0.0000 -0.0092
-0.0004
1.4356
SUM229PE
TNBC
-
Purvalanol A
CDK1
CDK
7537.067
uM
15.44060
22.47980
0.0008 -0.1830 0.8305 0.2246
0.9827
1.9773